Targeting Mantle Cell Lymphoma with Anti-SYK Nanoparticles.

about

Nanopharmacology in translational hematology and oncology Nanotechnology applications in hematological malignancies (Review).

P2860

Q33961538-BD3CA818-E0AD-4DDB-8AC2-26B195480D8D Q35934466-8F85C842-D4EF-40C4-863E-D89EB2B37771

P2860

Targeting Mantle Cell Lymphoma with Anti-SYK Nanoparticles.

Item

http://www.wikidata.org/entity/Q36889248

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Targeting Mantle Cell Lymphoma with Anti-SYK Nanoparticles.

@en

type

Item

label

Targeting Mantle Cell Lymphoma with Anti-SYK Nanoparticles.

@en

prefLabel

Targeting Mantle Cell Lymphoma with Anti-SYK Nanoparticles.

@en

P1476

Targeting Mantle Cell Lymphoma with Anti-SYK Nanoparticles

@en

P2093

Anoush Shahidzadeh

http://www.w3.org/2001/XMLSchema#string

Ingrid Cely

http://www.w3.org/2001/XMLSchema#string

Jianjun Cheng

http://www.w3.org/2001/XMLSchema#string

Qian Yin

http://www.w3.org/2001/XMLSchema#string

Seang Yiv

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

Therapeutic nanoparticles for drug delivery in cancer

Nanoparticle therapeutics: an emerging treatment modality for cancer

Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop.

Phase II study of gemcitabine-dexamethasone with or without cisplatin in relapsed or refractory mantle cell lymphoma.

An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin's lymphoma.

STAT3 is a substrate of SYK tyrosine kinase in B-lineage leukemia/lymphoma cells exposed to oxidative stress.

Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling.

Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.

P304

1-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.6000/1927-7229.2012.01.01.1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Li Tang

Fatih M. Uckun

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237014693

http://www.w3.org/2001/XMLSchema#string

P698

23730399

http://www.w3.org/2001/XMLSchema#string

P932

3668349

http://www.w3.org/2001/XMLSchema#string

Targeting Mantle Cell Lymphoma with Anti-SYK Nanoparticles.

about

P2860

P2860

Targeting Mantle Cell Lymphoma with Anti-SYK Nanoparticles.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932